Real-World Evidence Assessment of the Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide
- PMID: 39080859
- PMCID: PMC11529103
- DOI: 10.1177/19322968241268050
Real-World Evidence Assessment of the Risk of Nonarteritic Anterior Ischemic Optic Neuropathy in Patients Prescribed Semaglutide
Keywords: GLP-1RA; blindness; optic neuritis; real-world evidence; semaglutide.
Conflict of interest statement
Declaration of Conflicting InterestsThe author(s) declared the following potential conflicts of interest with respect to the research, authorship, and/or publication of this article: DCK is a consultant for Afon, Atropos Health, Glucotrack, Lifecare, Novo, Samsung, and Thirdwayv. GH and SG are employees of Atropos Health.
References
-
- Karim ME. High-dimensional propensity score and its machine learning extensions in residual confounding control [published online ahead of print June 17, 2024]. Am Stat. 2024. doi: 10.1080/00031305.2024.2368794. - DOI
Publication types
LinkOut - more resources
Full Text Sources